Yazici, O. Et Al. 2015. The importance of thiol/disulphide homeostasis in patients with advanced colorectal cancer receiving modified fluorouracil and leucoverin plus oxaliplatin (mFOLFOX) regimen. European Cancer Congress , (Vienna, Austria).

Yazici, O., Dogan, M., Erel, O., Bozkaya, Y., Ozdemir, N., Demirci, N. S., ... Neselioglu, S.(2015). The importance of thiol/disulphide homeostasis in patients with advanced colorectal cancer receiving modified fluorouracil and leucoverin plus oxaliplatin (mFOLFOX) regimen . European Cancer Congress, Vienna, Austria

Yazici, O. Et Al. "The importance of thiol/disulphide homeostasis in patients with advanced colorectal cancer receiving modified fluorouracil and leucoverin plus oxaliplatin (mFOLFOX) regimen," European Cancer Congress, Vienna, Austria, 2015

Yazici, O. Et Al. "The importance of thiol/disulphide homeostasis in patients with advanced colorectal cancer receiving modified fluorouracil and leucoverin plus oxaliplatin (mFOLFOX) regimen." European Cancer Congress , Vienna, Austria, 2015

Yazici, O. Et Al. (2015) . "The importance of thiol/disulphide homeostasis in patients with advanced colorectal cancer receiving modified fluorouracil and leucoverin plus oxaliplatin (mFOLFOX) regimen." European Cancer Congress , Vienna, Austria.

@conferencepaper{conferencepaper, author={O. Yazici Et Al. }, title={The importance of thiol/disulphide homeostasis in patients with advanced colorectal cancer receiving modified fluorouracil and leucoverin plus oxaliplatin (mFOLFOX) regimen}, congress name={European Cancer Congress}, city={Vienna}, country={Austria}, year={2015}}